Poloppin
Poloppin is a potent, cell penetrant inhibitor of the mitotic Polo-like kinase (PLK) (IC50=26.9 μM) and prevents the protein-protein interaction via the Polo-box domain (PBD) (Kd= 29.5 μM) . Poloppin selectively kills cells expressing mutant KRAS, enhancing death in mitosis. Poloppin is used for the study of KRAS-mutant cancers as single agents, or in combination with c-MET inhibitors[1].
Product Specifications
CAS Number
683808-78-8
UNSPSC
12352005
Target
Autophagy; Mitosis; Polo-like Kinase (PLK)
Type
Reference compound
Related Pathways
Autophagy; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/poloppin.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CCC1=CC=C(C2=CC=C(Br)C=C2)N1C3=CC=CC=C3C(F)(F)F
Molecular Formula
C20H15BrF3NO2
Molecular Weight
438.24
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![[1,2,3,4]Tetrazolo[1,5-a]quinoxalin-4-amine](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
